Page 133 - Read Online
P. 133
Musumeci et al. J Transl Genet Genom 2020;4:221-37 I https://doi.org/10.20517/jtgg.2020.22 Page 237
gene defects: Delineation of an emerging neurometabolic syndrome. J Inherit Metab Dis 2019;42:264-75
119. Trinh J, Imhoff S, Dulovic-Mahlow M, Kandaswamy KK, Tadic V, et al. Novel NAXE variants as a cause for neurometabolic disorder:
implications for treatment. J Neurol 2020;267:770-782.
120. Orsucci D, Ienco EC, Siciliano G, Mancuso M. Mitochondrial disorders and drugs: what every physician should know. Drugs Context
2019;8:212588.
121. Mancuso M, Galli R, Pizzanelli C, Filosto M, Siciliano G, et al. Antimyoclonic effect of levetiracetam in MERRF syndrome. J Neurol Sci
2006;243:97-9.
